Lv2
110 积分 2026-04-16 加入
Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1
14小时前
已完结
Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1
15小时前
已完结
Clinical and therapeutic significance of genetic profiling in adult T-cell leukemia/lymphoma
15小时前
已完结
Polycomb repressive complexes as therapeutic targets in hematologic malignancies
15小时前
已完结
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
6天前
已完结
Nonmyeloablative Conditioning Combined with Anti-CD117 Antibody Briquilimab in Older Adults with High-Risk AML and MDS
8天前
已关闭
Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice
8天前
已完结
Anti-KIT antibody, briquilimab, induces mast cell apoptosis and depletion in nonhuman primates
8天前
已完结
SUSTAINED EFFICACY AND SAFETY OF BARZOLVOLIMAB IN CINDU
8天前
已关闭
Anti-oxidative and anti-inflammatory effects of the phosphodiesterase 3/4 inhibitor ensifentrine
13天前
已完结
皖公网安备34019202002308
